These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31063075)

  • 21. Re: Inhibition of Urinary Stone Disease by a Multi-Species Bacterial Network Ensures Healthy Oxalate Homeostasis.
    Assimos DG
    J Urol; 2020 Jan; 203(1):25. PubMed ID: 31618152
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of different food forms on the urine composition and the risk of calcium oxalate stone formation].
    Siener R; Hesse A
    Z Ernahrungswiss; 1993 Mar; 32(1):46-55. PubMed ID: 8484269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relative risk periods for calcium oxalate stone formation: the circadian rhythm of formation in urine].
    Deng YL
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):555-8, 574. PubMed ID: 3243151
    [No Abstract]   [Full Text] [Related]  

  • 27. [Calcium oxalate activity products and discriminant analysis of urinary parameters as basis for a calcium oxalate screening program (author's transl)].
    Brundig P; Berg W; Naumann J; Hoppe H; Cumme GA; Achilles W; Schneider HJ
    Urologe A; 1980 Jan; 19(1):54-6. PubMed ID: 7355530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Plasma Oxalate in Relation to eGFR in Patients with Primary Hyperoxaluria, Enteric Hyperoxaluria and Urinary Stone Disease.
    Assimos DG
    J Urol; 2018 Apr; 199(4):887. PubMed ID: 29642351
    [No Abstract]   [Full Text] [Related]  

  • 29. A critical appraisal of the hypothesis that urine is a saturated equilibrium with respect to stone-forming calcium salts.
    Kavanagh JP
    BJU Int; 2001 May; 87(7):589-97; discussion 597-8. PubMed ID: 11350395
    [No Abstract]   [Full Text] [Related]  

  • 30. [Urinary material affecting calcium oxalate monohydrate stone formation].
    Shirane Y; Yamamoto A; Mizuta K; Hiraishi K; Kurokawa K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):995-9. PubMed ID: 2607720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of calcium oxalate crystallization by urinary macromolecules.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1991; 19(3):165-9. PubMed ID: 1887524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of short-term dietary changes on biochemical values in blood and urine and on some urinary risk factors for calcium oxalate stone formation in humans.
    Conyers RA; Need AG; Bracken A; Meyler M; Bais R; Rofe AM; Potezny N; Guerin M
    Int J Vitam Nutr Res Suppl; 1985; 28():135-52. PubMed ID: 3938802
    [No Abstract]   [Full Text] [Related]  

  • 36. Evening urinary oxalate excretion in stone formers.
    Banks JG; Sullivan M; Hargreave TB
    Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental calcium oxalate stone formation with clinical application.
    PRIEN EL; GERSHOFF SN; ANDRUS SB
    Rein Foie; 1962 Jun; 4():II/155-62. PubMed ID: 14488758
    [No Abstract]   [Full Text] [Related]  

  • 38. Gender differences in seasonal variation of urine stone risk factors.
    Parks JH; Barsky R; Coe FL
    J Urol; 2003 Aug; 170(2 Pt 1):384-8. PubMed ID: 12853781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M; Roux JO; Bourelly F; Boularan AM; Guiter J; Monnier L
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.